COVID-19 vaccine candidate developed by Duke-NUS and US firm to go into clinical trials

A COVID-19 vaccine candidate co-developed by Duke-National University of Singapore (NUS) Medical School and American biotech company Arcturus Therapeutics has received approval from authorities here to run clinical trials.